Orion Biotech Opportunities (Orion Biotech Opportunities) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Orion Biotech Opportunities's annualized Gross Profit for the quarter that ended in Dec. 2022 was $0.00 Mil. Orion Biotech Opportunities's average Total Assets over the quarter that ended in Dec. 2022 was $202.58 Mil. Therefore, Orion Biotech Opportunities's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2022 was 0.00%.

Orion Biotech Opportunities Gross-Profit-to-Asset % Historical Data

The historical data trend for Orion Biotech Opportunities's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Gross-Profit-to-Asset % Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Gross-Profit-to-Asset %

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Orion Biotech Opportunities's Gross-Profit-to-Asset %

For the Shell Companies subindustry, Orion Biotech Opportunities's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Biotech Opportunities's Gross-Profit-to-Asset % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Orion Biotech Opportunities's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Orion Biotech Opportunities's Gross-Profit-to-Asset % falls into.

Orion Biotech Opportunities Gross-Profit-to-Asset % Calculation

Orion Biotech Opportunities's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	0	/	( (201.362	+	203.333)	/ 2 )
	=	0	/	202.3475
	=	0.00 %

Orion Biotech Opportunities's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2022 )	/	( (Total Assets (Q: Sep. 2022 )	+	Total Assets (Q: Dec. 2022 ))	/ count )
	=	0	/	( (201.835	+	203.333)	/ 2 )
	=	0	/	202.584
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2022) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Orion Biotech Opportunities Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.